Hearing Loss News and Research RSS Feed - Hearing Loss News and Research

Hearing loss, impairment or deafness may be of two major types: one that develops some time in life, one that a baby is born with – or congenital deafness. Most commonly, hearing loss is seen with age or is caused by exposure to loud noises.
Chloride switch controls critical step in basement membrane formation

Chloride switch controls critical step in basement membrane formation

Chloride plays a key role in the formation of the basement membrane, a suprastructure on the outside of cells that undergirds and guides the function of most of the tissues of the body. [More]
Studies explore possible link between pediatric cancer and light therapy for newborn jaundice

Studies explore possible link between pediatric cancer and light therapy for newborn jaundice

Two new studies raise enough questions about a possible link between childhood cancer and light therapy for newborn jaundice that clinicians should exercise caution in prescribing the treatment for infants whose jaundice is likely to resolve on its own, a pediatric oncologist from Dana-Farber/Boston Children's Cancer and Blood Disorders Center argues in an editorial published today by the journal Pediatrics. [More]
Action on Hearing Loss funds new study to discover ways of preventing deafness caused by cancer drug

Action on Hearing Loss funds new study to discover ways of preventing deafness caused by cancer drug

A widely used anti-cancer drug, cisplatin, can cause permanent and severe hearing loss, having a devastating impact on the quality of life for cancer survivors. [More]
Effective chemotherapeutic drug may induce permanent hearing loss in Cockayne syndrome individuals

Effective chemotherapeutic drug may induce permanent hearing loss in Cockayne syndrome individuals

The chemotherapy drug cisplatin can kill cancer, but it can also cause permanent hearing loss. [More]
Synthetic heart valve one step closer to reality

Synthetic heart valve one step closer to reality

The quest for a synthetic heart valve that faithfully mimics the original is a step closer to its goal with the Rice University find that a natural polymer called hyaluronan, one of the chief components of skin and connective tissue, can serve as a versatile template for growing spongiosa, the middle tissue layer in the valve's leaflets. [More]
Innovative noise reduction technology SEDA helps tackle babble signals from cochlear implants

Innovative noise reduction technology SEDA helps tackle babble signals from cochlear implants

Wearers of cochlear implants and hearing aids often have difficulty teasing out what someone is saying over "babble" -- the cacophony of other talkers -- and other ambient sounds. New York University researchers have devised a novel solution: an algorithmic approach that, like making drinkable water from pond water, distills the talker's voice from a turbid wash of noise. [More]

Sense announces official launch of new deafblind awareness e-learning course for audiologists

Sense, the national deafblind charity, has today announced the official launch of its new deafblind awareness e-learning course, specifically designed for audiologists. [More]
First small molecule targeted therapy holds promise for Usher syndrome

First small molecule targeted therapy holds promise for Usher syndrome

Usher syndrome (USH) is characterized by hearing loss or deafness at birth and progressive vision loss, and is the most common cause of inherited dual sensory deficit. No treatment is currently available to stop or slow the progression of vision or hearing loss in USH3, one of three clinical classifications for USH that are further divided into subtypes and all associated with different genes. [More]
UK charity Action on Hearing Loss funds new project to develop medicines for hearing loss

UK charity Action on Hearing Loss funds new project to develop medicines for hearing loss

Today, UK charity Action on Hearing Loss announces a major investment to fund a new project to develop medicines to treat age-related hearing loss and noise-induced hearing loss at BioTrinity 2016 – Europe’s Leading Investment and Biopartnering Conference. [More]
Hearing aid use improves cognitive function in hearing-impaired older adults

Hearing aid use improves cognitive function in hearing-impaired older adults

A study conducted by researchers at Columbia University Medical Center found that older adults who used a hearing aid performed significantly better on cognitive tests than those who did not use a hearing aid, despite having poorer hearing. The study was published online in the American Journal of Geriatric Psychiatry. [More]
RA patients more likely to experience hearing loss

RA patients more likely to experience hearing loss

RA is the commonest autoimmune arthritis affecting 1% of the general population. Despite its main articular manifestations, RA caninvolveextra-articular organs including the auditory system. [More]
Scientists identify gene associated with cleft lip and palate

Scientists identify gene associated with cleft lip and palate

Leading scientists have identified an important gene that is associated with cleft lip and palate.Experts say the discovery is a step closer to understanding how this birth defect arises, and will help in the development of medical approaches to prevent the disfiguring condition. [More]
USF receives $9 million NIH grant to study unique treatment for age-related hearing loss

USF receives $9 million NIH grant to study unique treatment for age-related hearing loss

Researchers in the University of South Florida's Global Center for Hearing and Speech Research, recognized as the world's top research center for age-related hearing loss, have received a five-year, $9 million grant from the National Institutes of Health to study two unique ways to treat age-related hearing loss (ARHL). [More]
New hearing aid adjustment program may help increase hearing aid use for older adults

New hearing aid adjustment program may help increase hearing aid use for older adults

Hearing loss is the third most common chronic illness for older adults. It can impact everyday life and can significantly affect a person's health and safety if gone untreated. Hearing aids are the most common treatment for hearing loss. However, in 2005 more than 325,000 hearing aids, less than four years old were unused according to a previous study in the Hearing Journal. [More]
Anticancer drug restores hearing in neurofibromatosis patients

Anticancer drug restores hearing in neurofibromatosis patients

In a small clinical study with an anticancer drug that halts blood vessel growth, a handful of people with neurofibromatosis type 2 (NF2) and hearing loss had restoration of hearing. [More]
Enhanced diet helps slow progression of hereditary deafness

Enhanced diet helps slow progression of hereditary deafness

An enhanced diet helped reduce hearing loss in mice with the genetic mutation most commonly responsible for childhood deafness, new research suggests. [More]
Blueberry Therapeutics set to create safe, effective nanomedicines to tackle unmet healthcare needs

Blueberry Therapeutics set to create safe, effective nanomedicines to tackle unmet healthcare needs

Blueberry Therapeutics Ltd, a leading pharmaceutical company focused on the major medical problems of inflammation and infection, are exploring the anti-microbial agenda through the development of new anti-fungal drugs and treatments to tackle this important unmet healthcare need. [More]
New WHO report highlights ways to prevent, mitigate hearing loss in children

New WHO report highlights ways to prevent, mitigate hearing loss in children

Nearly 32 million children across the world live with disabling hearing loss. A new World Health Organization (WHO) report, Childhood hearing loss: act now, here’s how, suggests that 60% of this can be prevented. [More]
Study reveals role of 'Kurly' protein found in cilia

Study reveals role of 'Kurly' protein found in cilia

A new study of a protein found in cilia - the hair-like projections on the cell surface - may help explain how genetic defects in cilia play a role in developmental abnormalities, kidney disease and a number of other disorders. [More]
Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Amgen and UCB today announced top-line results from the Phase 3 placebo-controlled FRActure study in postmenopausal woMen with ostEoporosis (FRAME). [More]
Advertisement
Advertisement